Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

被引：0
|
作者：
Weiwei Huang
Chenxi Wang
Yangkun Shen
Qi Chen
Zhijian Huang
Jian Liu
Xiaoyan Lin
Lili Wang
Fan Wu
Xinhua Chen
Nani Li
Yi Hong
Mulan Chen
Jieyu Li
Chuanzhong Huang
机构：
[1] Fujian Medical University Union Hospital,Department of Medical Oncology
[2] Clinical Oncology School of Fujian Medical University,Department of Medical Oncology
[3] Fujian Cancer Hospital,Fujian Key Laboratory of Translational Cancer Medicine
[4] Fujian Cancer Hospotial,Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China
[5] Fujian Normal University Qishan Campus,Department of Breast Surgical Oncology
[6] Clinical Oncology School of Fujian Medical University,Laboratory of Immuno
[7] Fujian Cancer Hospital,Oncology
[8] Clinical Oncology School of Fujian Medical University,undefined
[9] Fujian Cancer Hospital,undefined
来源：
BMC Cancer | / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer (Vol 24, 39, 2024)
    Huang, Weiwei
    Wang, Chenxi
    Shen, Yangkun
    Chen, Qi
    Huang, Zhijian
    Liu, Jian
    Lin, Xiaoyan
    Wang, Lili
    Wu, Fan
    Chen, Xinhua
    Li, Nani
    Hong, Yi
    Chen, Mulan
    Li, Jieyu
    Huang, Chuanzhong
    BMC CANCER, 2024, 24 (01)
  • [2] A real-world study on the clinical value of apatinib-based regimens in metastatic triple-negative breast cancer
    Wei, H. W.
    Qi, C.
    Kun, S.
    Xi, W.
    Jian, H.
    Jian, L.
    Li, W.
    Fan, W.
    Chen, X.
    Ni, L.
    Yi, H.
    Lan, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S360 - S360
  • [3] Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer
    Skinner, Karen E.
    Haiderali, Amin
    Huang, Min
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (08) : 931 - 942
  • [4] Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population
    Garcia, Cristina Galindo
    Acedo, Rocio Diaz
    Criado, Silvia Artacho
    Artacho, Maria Rodriguez de la Borbolla
    FARMACIA HOSPITALARIA, 2024, 48 (06) : 278 - 285
  • [5] Real-world effectiveness outcomes by race in patients with metastatic triple negative breast cancer
    Skinner, K. E.
    Dufour, R.
    Haiderali, A.
    Huang, M.
    Schwartzberg, L. S.
    CANCER RESEARCH, 2019, 79 (04)
  • [6] Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
    Reinisch, Mattea
    Bruzas, Simona
    Spoenlein, Jennifer
    Shenoy, Satyendra
    Traut, Alexander
    Harrach, Hakima
    Chiari, Ouafaa
    Cremer, Efsthatia
    Ataseven, Beyhan
    Gubelt, Lars
    Kuemmel, Sherko
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [7] Real-world data comparing third and subsequent line regimens for treatment of metastatic triple-negative breast cancer in the United States.
    Aran, Dvir
    Klein-Brill, Avital
    Fisch, Michael Jordan
    Amar-Farkash, Shlomit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18765 - E18765
  • [8] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhang, Zheng
    Zhang, Yadi
    Liu, Chuanling
    Shao, Jiakang
    Chen, Yimeng
    Zhu, Yimin
    Zhang, Li
    Qin, Boyu
    Kong, Ziqing
    Wang, Xixi
    Wang, Yutong
    Huang, Deqin
    Liu, Liqun
    Zhou, Yuxin
    Tao, Ran
    Yang, Zengjie
    Liu, Mei
    Zhao, Weihong
    CANCER INNOVATION, 2023, 2 (03): : 172 - 180
  • [9] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study
    Carrion-Madronal, Isabel Maria
    Diaz-Acedo, Rocio
    Lora-Escobar, Santiago Jose
    Naranjo-Llamas, Eloisa
    Jaramillo-Ruiz, Didiana
    Artacho-Criado, Silvia
    Prado-Mel, Elena
    FUTURE ONCOLOGY, 2024, 20 (33) : 2565 - 2572
12345